Use of corticosteroids in glomerulonephritis related to infective endocarditis: Three cases and review

Clinical Infectious Diseases

Volumn 28, Issue 5, 1999, Pages 1057-1061

  Le Moing, Vincent ^a   Lacassin, Flore ^a   Delahousse, Michel ^a   Duval, Xavier ^a   Longuet, Pascale ^a   Leport, Catherine ^a   Vildé, Jean Louis ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIBODY; CEFOTAXIME; CIPROFLOXACIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CREATININE; DOXYCYCLINE; GENTAMICIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NETILMICIN; PEFLOXACIN; PREDNISONE; RHEUMATOID FACTOR; RIFAMPICIN;

AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOBACTERIUM; CASE REPORT; COXIELLA BURNETII; DRUG EFFICACY; FEMALE; GLOMERULONEPHRITIS; HUMAN; IMMUNOFLUORESCENCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; LATEX AGGLUTINATION TEST; MALE; NEPHELOMETRY; PRIORITY JOURNAL; STREPTOCOCCUS BOVIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0032938642     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514734     Document Type: Article

References (31)

1. 1. Neugarten J, Gallo GR, Baldwin DS. Glomerulonephritis in bacterial endocarditis. Am J Kidney Dis 1984; 3:371-9.
2. 2. Bayer AS, Theofilopoulos AN. Immunopathogenetic aspects of infective endocarditis. Chest 1990; 97:204-2.
3. 3. Bayer AS, Theofilopoulos AN, Eisenberg R, Dixon FJ, Guze LB. Circulating immune complexes in infective endocarditis. N Engl J Med 1976; 295:1500-5.
4. 4. Cabane J, Godeau P, Herreman G, Acar J, Digeon M, Bach J-F. Fate of circulating immune complexes in infective endocarditis. Am J Med 1979; 66:277-82.
5. 5. Kauffmann RH, Thompson J, Valentijn RM, Daha MR, Van Es L. The clinical implications and the pathogenetic significance of circulating immune complexes in infective endocarditis. Am J Med 1981; 71:17-25.
6. 6. Gutman RA, Striker GE, Gilliland BC, Cutler RE. The immune complex glomerulonephritis of bacterial endocarditis. Medicine (Baltimore) 1972; 51:1-25.
7. 7. Perez GO, Rothfield N, Williams RC. Immune-complex nephritis in bacterial endocarditis. Arch Intern Med 1976; 136:334-6.
8. 8. Boullon-Jones JM, Sissons JGP, Evans DJ, Peters DK. Renal lesions in subacute infective endocarditis. Br Med J 1974; 2:11-4.
9. 9. Ayres BF, Bastian PD, Haines D, et al. Renal and cardiac complications of drug abuse. Med J Aust 1976; 2:489-94.
10. 10. Rovzar MA, Logan JL, Ogden DA, Graham AR. Immunosuppressive therapy and plasmapheresis in rapidly progressive glomerulonephritis associated with bacterial endocarditis. Am J Kidney Dis 1986; 7: 428-33.
11. 11. McKenzie PE, Taylor AE, Woodroffe AJ, Seymour AE, Chan Y-L, Clarkson AR. Plasmapheresis in glomerulonephritis. Clin Nephrol 1979; 12:97-108.
12. 12. McKinsey DS, McMurray TL, Flynn JM. Immune complex glomerulonephritis associated with Staphylococcus aureus bacteremia: response to corticosteroid therapy. Rev Infect Dis 1990; 12:125-7.
13. 13. Montseny JJ, Meyrier A, Kleinknecht D, Callard P. The current spectrum of infectious glomerulonephritis: experience with 76 patients and review of the literature. Medicine (Baltimore) 1995; 74:63-73.
14. 14. Durack DT, Lukes AS, Bright DK, the Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96:200-9.
15. 15. Loburn JW, Agre KL. Renal thromboembulism, atheroembolism and other acute diseases of the renal arteries. In: Sehrer RW, Gottschalck CW, eds. Diseases of the kidney. Philadelphia: WB Saunders, 1993: 2119-35.
16. 16. Lortholary O, Tod M, Cohen Y, Petitjean O. Aminoglycosides. Med Clin North Am 1995; 79:761-87.
17. 17. Scheld WM, Sand MA. Endocarditis and intravascular infections. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. 5th ed. New York: Churchill Livingstone, 1995:740-83.
18. 18. Raoult D. Treatment of Q fever. Antimicrob Agents Chemother 1993; 37: 1733-6.
19. 19. Delahaye F, Goulet V, Lacassin F, et al. Characteristics of infective endocarditis in France in 1991: a 1-year survey. Eur Heart J 1995; 16: 394-401.
20. 20. Lane T, MacGregor RR, Wright D, Hollander J. Cardiobacterium hominis: an elusive cause of endocarditis. J Infect 1983; 6:75-80.
21. 21. Wormser GP, Battone EJ. Cardiobacterium hominis: review of microbiologic and clinical features. Rev Infect Dis 1983; 5:680-91.
22. 22. Levy P, Raoult D, Razongles JJ. Q-fever and autoimmunity. Cur J Epidemiol 1989; 5:447-53.
23. 23. Fest T, De Wazieres B, Dupond JL. Syndrome d'Evans et anticoagulant pseudolupique au cours d'une endocardite à fièvre Q. Ann Med Interne (Paris) 1990; 141:79-80.
24. 24. Ordi-Ros J, Selva-O'Callaghan A, Monegal-Ferran F, Monasterio-Aspiri Y, Juste-Sanchez C, Vilardell-Tarres M. Prevalence, significance and specificity of antibodies to phospholipids in Q fever. Clin Infect Dis 1994; 18:213-8.
25. 25. Garcia-Alfranca F, Clemente-Rodriguez C, Pigrau-Serrallach C, Fonollosa-Pla V, Villardell-Tarres M. Q fever associated with persistent fever: aun immunologie disorder? Clin Infect Dis 1994; 18:122-3.
26. 26. Varma MPS, Adgey AAJ, Connolly JH. Chronic Q fever endocarditis. Br Heart J 1980; 43:695-9.
27. 27. Tobin MJ, Cahill N, Gearty G, et al. Q fever endocarditis. Am J Med 1982; 72:396-400.
28. 28. Korman TM, Spelman DW, Perry GJ, Dowling JP. Acute glomerulonephritis associated with acute Q fever: case report and review of the renal complications of Coxiella burnetii infection. Clin Infect Dis 1998; 26: 359-64.
29. 29. Lerner PI, Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med 1966; 274:199-206, 259-66, 323-31.
30. 30. Pelletier LL, Petersdorf RG. Infective endocarditis: a review of 125 cases from the University of Washington hospitals 1963-72. Medicine (Baltimore) 1977; 56:287-313.
31. 31. Boyd RE, Birchmore DA, Kaiser DL, Young AC, Davis JS. Acute effects of steroids on immune complex: profile of patients with systemic lupus erythematosus. Arthritis Rheum 1983; 26:637-44.